论文信息 - Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis - 字舞流文

Overall survival benefits of first-line EGFR tyrosine kinase inhibitors in EGFR-mutated non-small-cell lung cancers: a systematic review and meta-analysis

Kuan-Der Lee | Cheng-Ta Yang | Liang-Tseng Kuo | Min-Chi Chen | C. Shi | F. Kuan | David Teng